Cargando…

Immune infiltrating cells in duodenal cancers

BACKGROUND: Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the disease and of its biology, limiting the identification of tailored therapeutic options. A l...

Descripción completa

Detalles Bibliográficos
Autores principales: Donisi, G., Capretti, G., Cortese, N., Rigamonti, A., Gavazzi, F., Nappo, G., Pulvirenti, A., Sollai, M., Spaggiari, P., Zerbi, A., Marchesi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470614/
https://www.ncbi.nlm.nih.gov/pubmed/32883314
http://dx.doi.org/10.1186/s12967-020-02508-4
_version_ 1783578617383485440
author Donisi, G.
Capretti, G.
Cortese, N.
Rigamonti, A.
Gavazzi, F.
Nappo, G.
Pulvirenti, A.
Sollai, M.
Spaggiari, P.
Zerbi, A.
Marchesi, F.
author_facet Donisi, G.
Capretti, G.
Cortese, N.
Rigamonti, A.
Gavazzi, F.
Nappo, G.
Pulvirenti, A.
Sollai, M.
Spaggiari, P.
Zerbi, A.
Marchesi, F.
author_sort Donisi, G.
collection PubMed
description BACKGROUND: Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the disease and of its biology, limiting the identification of tailored therapeutic options. A large body of evidence has clearly shown the clinical relevance of immune cells in solid tumors, correlating immune features with post-surgical prognosis. The aim of this study was to analyze the immune contexture in a cohort of duodenal adenocarcinomas surgically resected at our Institution and define its correlation with clinical variables. METHODS: Tissue slides from paraffin-embedded tumor specimens of 15 consecutive DA and 3 adenomas that underwent a pancreaticoduodenectomy in our center between 2010 to 2018 were immunohistochemically stained. The density (percentage of immune reactive area, IRA%) of immune markers CD45RO, CD8, CD20, IL-17, PD-1, CD68 was quantified by computer-assisted image analysis. Demographic, clinical, histopathological data were collected. RESULTS: In our population, median IRA % (IQR) of immune subsets was respectively CD45RO-TILs 2.19 (2.14), CD8-TIL 0.42 (0.81), CD20-TILs 0.22 (0.51), CD20-TLT 2.84 (4.64), CD68-TAM 2.19 (1.56), IL17(+) cells 0.39 (0.39), PD1-TILs 0.19 (0.41). The median follow-up was 47.5 (22.4–63.3) months. At statistical analysis, the density of CD8-TILs inversely correlated with lymph node ratio (p = 0.013), number of metastatic lymph nodes (p = 0.019), and was lower in N+ adenocarcinomas compared to N0 (1.07 vs 0.29; p = 0.093), albeit not significantly. Stratifying patients for the N status, the density of CD8-TILs decreased with the increasing of the N stage (p = 0.065) and was lower in patients who experienced recurrence and died for the disease (0.276 vs 0.641; p = 0.044). Notably, also CD68-TAM distribution was different in patients who had recurrence versus patients who did not (1.028 vs 2.276; p = 0.036). CONCLUSIONS: Immune cells showed variable expression in correlation with common prognostic factors, suggesting T cell infiltration may play a protective role towards lymphatic spread of disease and nodal metastatization. Furthermore, T cell density and macrophage infiltration were associated to a lower risk of recurrence and disease related death. A multicentric approach may be indicated to allow analysis of larger cohorts of patients, potentially increasing the power of our observations.
format Online
Article
Text
id pubmed-7470614
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74706142020-09-08 Immune infiltrating cells in duodenal cancers Donisi, G. Capretti, G. Cortese, N. Rigamonti, A. Gavazzi, F. Nappo, G. Pulvirenti, A. Sollai, M. Spaggiari, P. Zerbi, A. Marchesi, F. J Transl Med Research BACKGROUND: Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the disease and of its biology, limiting the identification of tailored therapeutic options. A large body of evidence has clearly shown the clinical relevance of immune cells in solid tumors, correlating immune features with post-surgical prognosis. The aim of this study was to analyze the immune contexture in a cohort of duodenal adenocarcinomas surgically resected at our Institution and define its correlation with clinical variables. METHODS: Tissue slides from paraffin-embedded tumor specimens of 15 consecutive DA and 3 adenomas that underwent a pancreaticoduodenectomy in our center between 2010 to 2018 were immunohistochemically stained. The density (percentage of immune reactive area, IRA%) of immune markers CD45RO, CD8, CD20, IL-17, PD-1, CD68 was quantified by computer-assisted image analysis. Demographic, clinical, histopathological data were collected. RESULTS: In our population, median IRA % (IQR) of immune subsets was respectively CD45RO-TILs 2.19 (2.14), CD8-TIL 0.42 (0.81), CD20-TILs 0.22 (0.51), CD20-TLT 2.84 (4.64), CD68-TAM 2.19 (1.56), IL17(+) cells 0.39 (0.39), PD1-TILs 0.19 (0.41). The median follow-up was 47.5 (22.4–63.3) months. At statistical analysis, the density of CD8-TILs inversely correlated with lymph node ratio (p = 0.013), number of metastatic lymph nodes (p = 0.019), and was lower in N+ adenocarcinomas compared to N0 (1.07 vs 0.29; p = 0.093), albeit not significantly. Stratifying patients for the N status, the density of CD8-TILs decreased with the increasing of the N stage (p = 0.065) and was lower in patients who experienced recurrence and died for the disease (0.276 vs 0.641; p = 0.044). Notably, also CD68-TAM distribution was different in patients who had recurrence versus patients who did not (1.028 vs 2.276; p = 0.036). CONCLUSIONS: Immune cells showed variable expression in correlation with common prognostic factors, suggesting T cell infiltration may play a protective role towards lymphatic spread of disease and nodal metastatization. Furthermore, T cell density and macrophage infiltration were associated to a lower risk of recurrence and disease related death. A multicentric approach may be indicated to allow analysis of larger cohorts of patients, potentially increasing the power of our observations. BioMed Central 2020-09-03 /pmc/articles/PMC7470614/ /pubmed/32883314 http://dx.doi.org/10.1186/s12967-020-02508-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Donisi, G.
Capretti, G.
Cortese, N.
Rigamonti, A.
Gavazzi, F.
Nappo, G.
Pulvirenti, A.
Sollai, M.
Spaggiari, P.
Zerbi, A.
Marchesi, F.
Immune infiltrating cells in duodenal cancers
title Immune infiltrating cells in duodenal cancers
title_full Immune infiltrating cells in duodenal cancers
title_fullStr Immune infiltrating cells in duodenal cancers
title_full_unstemmed Immune infiltrating cells in duodenal cancers
title_short Immune infiltrating cells in duodenal cancers
title_sort immune infiltrating cells in duodenal cancers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470614/
https://www.ncbi.nlm.nih.gov/pubmed/32883314
http://dx.doi.org/10.1186/s12967-020-02508-4
work_keys_str_mv AT donisig immuneinfiltratingcellsinduodenalcancers
AT caprettig immuneinfiltratingcellsinduodenalcancers
AT cortesen immuneinfiltratingcellsinduodenalcancers
AT rigamontia immuneinfiltratingcellsinduodenalcancers
AT gavazzif immuneinfiltratingcellsinduodenalcancers
AT nappog immuneinfiltratingcellsinduodenalcancers
AT pulvirentia immuneinfiltratingcellsinduodenalcancers
AT sollaim immuneinfiltratingcellsinduodenalcancers
AT spaggiarip immuneinfiltratingcellsinduodenalcancers
AT zerbia immuneinfiltratingcellsinduodenalcancers
AT marchesif immuneinfiltratingcellsinduodenalcancers